1/30/2023  11:56:19 AM Chg. -0.20 Volume Bid12:15:52 PM Ask12:15:52 PM Market Capitalization Dividend Y. P/E Ratio
76.70CHF -0.26% 35
Turnover: 2,690.50
76.70Bid Size: 105 77.00Ask Size: 225 907.5 mill.CHF 0.00% 132.59

Business description

As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland.
 

Management board & Supervisory board

CEO
Christoph Brönnimann
Management board
Dirk Kirsten, Anthony Durieux-Menage, Axel Maltzen, Lisa Thompson, Manuel Schaer, Mareike Loch
Supervisory board
Marco Gadola, Dr h.c. Thomas Straumann, Damien Tappy, Dominik Ellenrieder, Dr. Jürg Greuter, Dr. med. Daniel B. Herren, Roland Hess, Willi Miesch
 

Company data

Name: Medartis Holding AG
Address: Hochbergstraße 60E,CH-4057 Basel
Phone: +41-61-633-3736
Fax: -
E-mail: info@medartis.com
Internet: www.medartis.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: -
IPO date: 3/23/2018

Investor relations

Name: Fabian Hildbrand
IR phone: -
IR Fax: -
IR e-mail: investor.relations@m...tis.com investor.relations@medartis.com

Company calendar

CW 11 | 3/14/2023 4th Quarter/Annual Report
CW 16 | 4/21/2023 General Shareholder Meeting
CW 33 | 8/15/2023 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Dr. h.c. Thomas Straumann
 
47.61%
Freefloat
 
26.77%
NexMed Holding AG
 
7.80%
Endeavour Medtech Growth LP
 
6.59%
Nordflint Capital Partners Fondsmaeglerselskab A/S
 
6.00%
Willi Miesch
 
5.23%